Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Affiliations

• ¹ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ² Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ³ Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
• ⁴ Eiger BioPharmaceuticals, Palo Alto, CA, USA.
• ⁵ Departments of Medicine and Microbiology and Immunology, Stanford University, Stanford, CA, USA.
• ⁶ Palo Alto Veterans Administration, Palo Alto, CA, USA.
• ⁷ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
• ⁸ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
• ⁹ Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill, NC, USA. rbaric@email.unc.edu.